PharVision Advisers’s Crescent Energy CRGY Stock Holding History

PharVision Advisers’s Portfolio CRGY Stock Details CRGY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,683	Closed	-$148K	–	230
2025 Q4	$148K	Sell	17,683 -3,883	-18%	-$34.1K	0.08%	614
2025 Q3	$192K	Buy	+21,566	New	+$196K	0.11%	525
2025 Q1	–	Sell	-18,265	Closed	-$267K	–	318
2024 Q4	$267K	Buy	+18,265	New	+$248K	0.23%	193

Other funds holding CRGY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LMGAM

Liberty Mutual Group Asset Management Boston, Massachusetts $1.25B AUM 45.27% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PharVision Advisers's CRGY Position: Q1 2026 in Review

PharVision Advisers sold out of Crescent Energy (CRGY) in Q1 2026, closing a stake of 17,683 shares — an estimated $148K sold.

PharVision Advisers first reported a position in CRGY in Q4 2024 and held it in 3 quarters. The position peaked at $267K in Q4 2024. 358 funds tracked by Wall St. Rank hold CRGY as of Q1 2026.

PharVision Advisers reported no remaining Crescent Energy position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 17,683 Crescent Energy shares in Q1 2026, an estimated $148K.
PharVision Advisers first reported a position in Crescent Energy in Q4 2024 and held it in 3 quarters.
PharVision Advisers's Crescent Energy position peaked at $267K in Q4 2024.
358 funds tracked by Wall St. Rank held Crescent Energy as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.